The FDA has approved the Novavax COVID-19 vaccine, albeit with unusual restrictions that limit its use to older adults and individuals at high risk. This decision comes after a delay in the approval process, now including stricter conditions to ensure the vaccine is administered safely. The approval marks a significant step for Novavax, allowing it to gain traction in the ongoing fight against COVID-19.